MTA1 drives malignant progression and bone metastasis in prostate cancer.

Mol Oncol · 2018 · PMC6120234 · PMID 30027683

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Figure 2 C, D shows highly significant differences in tumor volumes between control and shMTA1 xenografts by day 35, when mice were sacrificed.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.